UnitedHealth stock jumps after Medicare Advantage rate boost
UnitedHealth Group saw a significant increase in its shares, rising over 8% after federal regulators announced a higher-than-expected Medicare Advantage payment hike. This news brought relief to the health insurance giant and the managed-care sector as a whole.
The stock surged from $281.41 at the close of Monday to over $305 in intraday trading following the announcement by the Centers for Medicare & Medicaid Services, representing a gain of approximately 8.5% in a single session.
After a challenging period for the stock, this latest rally provided a positive turn for UnitedHealth Group.
UnitedHealth shares had faced a decline following the tragic death of UnitedHealthcare CEO Brian Thompson in December 2024 and continued to slide in the subsequent months due to various factors such as reputational issues, increasing costs, and regulatory pressures.
CMS announced a 2.48% average increase in Medicare Advantage payments for 2027, a significant rise from the 0.09% initially proposed earlier in the year.
Considering estimated risk-score trends, the agency stated that payments would see a 4.98% increase.
The upward revision in the finalized rate resulted in a multibillion-dollar increase, leading to a surge in insurer shares.
UnitedHealth Group, being the largest Medicare Advantage insurer by enrollment, is particularly impacted by government reimbursement levels, with even minor changes having a substantial financial effect.
CMS estimated that the revised rate would translate to over $13 billion in additional payments to insurers in 2027.
Earlier in the year, concerns were raised about mounting margin pressure on insurers due to rising medical costs following CMS’s initial proposal.
However, CMS decided to maintain the current risk-adjustment model for 2027 instead of implementing an overhaul, providing more stability for insurers in the Medicare Advantage market.
This decision significantly reduced the negative impact from risk-model changes and contributed to the higher final rate.
Regulators are taking a more cautious approach to support the Medicare Advantage program while ensuring payment accuracy.
Following the announcement, other managed-care stocks also experienced an increase as investors adjusted their expectations for revenue and profitability in 2027.
UnitedHealth, with its extensive reach and revenue dependence on CMS payments, is particularly sensitive to federal reimbursement rate changes, which directly affect its financial outlook.
